Related Articles
Phase 2 study of CHOP‑R‑14 followed by 90Y‑ibritumomab tiuxetan in patients with previously untreated diffuse large B‑cell lymphoma
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab
Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
Complete response to azacitidine priming and nab‑paclitaxel in non‑Hodgkin lymphoma resistant to biochemotherapy